Cover Image
Market Research Report
Product code 
1066295

IVD Procedure Volumes 2021-2026

Published: | Kalorama Information | Delivery time: 1-2 business days

Price

Back to Top
IVD Procedure Volumes 2021-2026
Published: March 22, 2022
Kalorama Information
Delivery time: 1-2 business days
  • Description
  • Table of Contents

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information's “ IVD Test Procedure Volumes, 2021-2026 ” saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

The report estimates IVD test procedure volume and IVD pricing for the following segments:

  • Worldwide IVD Market and Test Volume
  • Point-of-Care (POC) Market and Test Volume
  • Clinical Chemistry Market and Test Volume
  • Molecular Market and Test Volume
  • Hematology Market and Test Volume
  • Coagulation Market and Test Volume
  • Microbiology Market and Test Volume
  • Blood Banking Market and Test Volume
  • COVID-19 Market and Test Volume
  • Histology/Cytology Market and Test Volume
  • Immunoassay Market and Test Volume
  • IVD Testing Segments and Global IVD Markets

“ IVD Test Procedure Volumes, 2021-2026 ” includes profiles of the top IVD market competitors, looking in detail where possible at procedural volume by type. The companies covered are the following:

  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Dexcom
  • DiaSorin
  • Exact Sciences
  • Hologic, Inc.
  • Illumina
  • Ortho Clinical Diagnostics (Ortho)
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen
Product Code: 22-025

Table of Contents

Chapter One: Executive Summary

  • Figure 1-1: Global IVD Procedure Volumes, 2021 and 2026, (in millions $)
  • IVD Procedure Volume Estimate and Forecast
  • Scope & Methodology
  • About Kalorama Information

Chapter Two: Introduction

  • Industry Trends
    • Table 2-1: Global IVD Procedural Volume & Product Sales (includes glucose tests), 2021-2026
  • COVID 19

Chapter Three: Healthcare Trends

  • Overview
  • Demographic Trends
  • Global Population and Aging
    • Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
  • Workforce Reduction
    • Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
  • Addressing the Aging Trend
  • Emerging and Emerged Markets
    • Table 3-3: Market Potential by Total Population, and Percent Urban 2021 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)

Chapter Four: IVD Testing Segments

  • IVD Testing Trends
    • Table 4-1: IVD Procedural Volume including blood glucose tests (millions), 2021-2026
    • Table 4-2: IVD Procedural Volume excluding blood glucose tests (millions), 2021-2026
  • Segment Growth Projections
  • POC Testing
  • Clinical Chemistry
  • Immunoassays
  • Mass Spectrometry (Immuno)
  • Molecular Assays
  • Hematology
  • Coagulation
  • Conventional Microbiology
  • Blood Grouping/Typing
  • Histology/Cytology
    • Table 4-3: IVD Product Sales including blood glucose tests ($ millions), 2021-2026
    • Table 4-4 IVD Product Sales excluding blood glucose tests ($ millions), 2021-2026

Chapter Five: Global IVD Markets

  • General
    • Table 5-1: IVD Procedural Volume excluding blood glucose tests by Region (millions), 2021-2026
    • Table 5-2: IVD Product Sales excluding blood glucose tests by Region ($ millions), 2021-2026
  • North America
  • United States
  • Canada
  • Mexico, Central & South America
  • Brazil
  • Mexico
  • Other Central & South America
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Venezuela
  • All Other Countries & Territories
  • Western Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Other Western Europe
  • Netherlands
  • Belgium
  • Austria
  • Sweden
  • Switzerland
  • Denmark
  • Portugal
  • Norway
  • Greece
  • Ireland
  • Finland
  • All Other Countries & Territories
  • Eastern Europe
  • Russia
  • Other Eastern Europe
  • Poland
  • Romania
  • Czech Republic
  • Ukraine
  • Hungary
  • All Other Countries
  • Asia/Pacific
  • China
  • Japan
  • Other Asian Countries and Territories
  • India
  • South Korea
  • Australia
  • Taiwan
  • Vietnam
  • Pakistan
  • Thailand
  • Malaysia
  • Indonesia
  • Hong Kong
  • Philippines
  • Singapore
  • New Zealand
  • All Other Countries & Territories
  • Middle East
  • Turkey
  • Other Middle East
  • Iran
  • Saudi Arabia
  • Iraq
  • Israel
  • United Arab Emirates
  • All Other Countries
  • Africa
  • Egypt
  • South Africa
  • Nigeria
  • All Other Countries & Territories

Chapter Six: Point-of-Care (POC) Procedures

  • Global POC Procedure Volume by Test Type
    • Table 6-1: Total POC Procedural Volume & Product Sales including blood glucose tests, 2021-2026
    • Table 6-2: Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2021-2026
    • Figure 6-1: US/ROW POC Procedure Volumes excluding blood glucose tests by Percent 2026
    • Figure 6-2: US/ROW POC Sales excluding blood glucose sales by Percent 2026
  • POC Self Tests
    • Table 6-3: POC Self-Test Procedural Volume by Type (millions), 2021-2026
  • Traditional Blood Glucose Monitoring Activities
  • Continuous Blood Glucose Monitoring
  • Pregnancy and Fertility Testing
  • Coagulation Testing
  • Fecal Occult Blood Testing
  • Drugs of Abuse Testing
  • Pylori Testing
  • HIV Testing
  • Infectious Disease
  • Cholesterol Testing
  • POC Urinalysis Testing
  • Other POC Self-Testing
  • POC Self-Testing Product Sales
    • Table 6-4: POC Self-Test Product Sales by Type ($ millions), 2021-2026
  • Pricing Trends
    • Table 6-5: POC Self-Test $ IVD Product Sales Per Procedure, 2021-2026
  • POC Professional Testing
    • Table 6-6: POC Professional Procedural Volume by Type (millions), 2021-2026
  • POC Professional Blood Glucose Testing Procedures
  • POC Professional Critical Care Testing
  • POC Fertility Testing
  • POC Professional Infectious Disease Testing
  • POC Professional Cardiac Marker Testing
  • POC Professional Cholesterol/Lipid Testing
  • POC Professional Coagulation Testing
  • POC Professional HbA1C Testing
  • POC Professional Hematology Testing
  • POC Professional Fecal Occult Blood Screening
  • POC Professional Drugs of Abuse Testing
  • POC Professional Urinalysis Testing
  • Other POC Professional Testing
  • POC IVD Product Sales
    • Table 6-7: POC Professional IVD Product Sales by Type ($ millions), 2021-2026
  • Pricing Trends
    • Table 6-8: POC Professional $ IVD Products Per Procedure by Type (millions), 2021-2026

Chapter Seven: Clinical Chemistry Procedures

  • Table 7-1: Clinical Chemistry Procedural Volume by Type (millions), 2021-2026
  • Figure 7-1: US/ROW Clinical Chemistry Procedure Volumes by Percent 2026
  • Types of Tests
  • General Chemistry
  • Enzymes
  • Glucose
  • Lipids
  • Proteins
  • Other Compounds
  • Blood Gases & Electrolytes
  • Urinalysis
  • Global Sales of Clinical Chemistry Products
    • Table 7-2: Clinical Chemistry Product Sales by Type ($ millions), 2021-2026
    • Figure 7-2: US/ROW Clinical Chemistry Sales by Percent 2026
  • Pricing Trends
    • Table 7-3: Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2021-2026

Chapter Eight: Immunoassay Procedures

  • Technologies
  • Labeling Techniques
  • Enzyme Immunoassays
  • Fluorescence Polarization Immunoassays (FPIAs)
  • Radioimmunoassays (RIAs)
    • Table 8-1: Immunoassay Procedural Volume by Type (millions), 2021-2026
    • Figure 8-1: US/ROW Immunoassay Procedure Volumes by Percent 2026
  • Testing Procedures & Product Sales
    • Table 8-2: Immunoassay Product Sales by Type (millions), 2021-2026
    • Figure 8-2: US/ROW Immunoassay Sales by Percent 2026
  • Cardiac Markers
  • Tumor Markers
  • Autoimmune Conditions
  • Allergy Conditions
  • Thyroid Conditions
  • Proteins
  • Anemia
  • Fertility Testing
  • Therapeutic Drug Monitoring
  • Vitamin D
  • Diabetes/HbA1c
  • Drugs of Abuse
  • Infectious Diseases
    • Table 8-3: Immunoassay Infectious Disease exc Blood Screening Immuno Procedural Volume by Type (millions), 2021-2026
    • Table 8-4: Immunoassay Infectious Disease exc Blood Screening Immuno Product Sales by Type ($ millions), 2021-2026
  • Instruments
  • Pricing Trends
    • Table 8-5: Immunoassay $ Product Sales Per Procedure by Type, 2021-2026

Chapter Nine: Molecular Testing Procedures

  • Table 9-1: Molecular Assay Procedural Volume by Type (millions), 2021-2026
  • Figure 9-1: US/ROW Molecular Assay Procedure Volumes by Percent 2026
  • Types of Test
  • Testing Technologies
  • Infectious Diseases
    • Table 9-2: Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2021-2026
  • Blood Screening
  • Cancer
  • Transplant Matching
  • Thrombophilia SNPs
  • Inherited Diseases
  • Other Molecular Tests
  • Prenatal
  • Global Sales of Molecular IVD Products
    • Table 9-3: Molecular Assay Product Sales by Type ($ millions), 2021-2026
    • Figure 9-2 : US/ROW Molecular Assay Sales by Percent 2026
    • Table 9-4: Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2021-2026
  • Pricing Trends
    • Table 9-5: Molecular Assays $ Products per Procedure by Type, 2021-2026

Chapter Ten: Laboratory-Based Hematology Procedures

  • Table 10-1: Laboratory-Based Hematology Procedural Volume by Type (millions), 2021-2026
  • Figure 10-1: US/ROW Laboratory-Based Hematology Procedure Volumes by Percent 2026
  • Types of Tests
  • Global Sales of Hematology Products
    • Table 10-2: Laboratory-Based Hematology Product Sales by Type ($ millions), 2021-2006
    • Figure 10-2: US/ROW Hematology Sales by Percent 2026
  • Pricing Trends
    • Table 10-3: Hematology $ Product Sales Per Procedure by Type, 2021-2026

Chapter Eleven: Coagulation Testing Procedures

  • Table 11-1: Coagulation Procedural Volume (millions), 2021-2026
  • Figure11-1: US/ROW Coagulation Procedure Volumes by Percent 2026
  • Types of Tests
  • Global Sales of Coagulation Products
    • Table 11-2: Coagulation Product Sales ($ millions), 2021-2026
    • Figure 11-2: US/ROW Coagulation Sales by Percent 2026
  • Pricing Trends
    • Table 11-3: Coagulation $ Products per Procedure, 2021-2026

Chapter Twelve: Microbiology Procedures

  • Table 12-1: Conventional Microbiology Procedural Volume by Type (millions), 2021-2026
  • Figure 12-1: US/ROW Microbiology Procedure Volumes by Percent 2026
  • Types of Tests
  • ID/AST Automated Panels & Reagents
  • Manual Panels & Reagents
  • Blood Culture
  • Chromogenic Media
  • Rapid Microbiological Tests
  • Mass Spectrometry
  • Global Sales of Conventional IVD Microbiology Products
  • ID/AST Panels & Reagents
  • Blood Culture
  • Chromogenic Media
  • Rapid Microbiological Tests
  • Mass Spectrometry
    • Table 12-2: Conventional Microbiology Product Sales by Type ($ millions), 2021-2026
    • Figure 12-2: US/ROW Microbiology Sales by Percent 2026
  • Pricing Trends
    • Table 12-3: Conventional Microbiology $ Product Sales Per Procedures by Type, 2021-2026

Chapter Thirteen: Blood Grouping/Typing Procedures

  • Table 13-1: Blood Grouping/Typing Procedure Volumes ($ millions), 2021-2026
  • Figure 13-1: US/ROW Blood Grouping/Typing Procedure Volumes by Percent 2026
  • Types of Tests
  • Blood Grouping/Typing Product Sales
    • Table 13-2: Blood Grouping/Typing Product Sales ($ millions), 2021-2026
    • Figure 13-2: US/ROW Blood Grouping/Typing Sales by Percent 2026
  • Pricing Trends
    • Table 13-3: Blood Grouping/Matching $ Product Sales/Procedure, 2021-2026

Chapter Fourteen: Histology/Cytology Procedures

  • Table 14-1: Histology/Cytology Procedural Volume by Type (millions), 2021-2026
  • Figure 14-1: US/ROW Histology/Cytology Procedure Volumes by Percent 2026
  • Types of Tests
  • Pap Tests
  • In Situ Hybridization Tests
  • Immunohistochemistry Tests
  • Traditional Non-Pap Stains
  • Circulating Tumor Cells
  • Flow Cytometry
  • Histology/Cytology IVD Product Sales
    • Table 14-2: Histology/Cytology Product Sales by Type ($ millions), 2021-2026
    • Figure 14-2: US/ROW Histology/Cytology Sales by Percent 2026
  • Pricing Trends
    • Table 14-3: Histology/Cytology $ Product Sales Per Procedure by Type, 2021-2026

Chapter Fifteen: Company Profiles

  • Table 15-1: Revenues of Selected Top 19 IVD Companies, 2017-2021 ($ million)
  • Abbott Diagnostics
  • Recent Revenue History
    • Table 15-2: Abbott Diagnostic Revenues 2017-2021 (millions $)
  • Alere Acquisition Update and Point of Care
  • Core Lab
  • Hematology
  • Blood Banking
  • Infectious Diseases - Molecular
  • Diabetes
  • HIV Point of Care
  • i-STAT Business
  • Agilent Technologies
  • Recent Revenue History
    • Table 15-3: Agilent Revenues 2017-20121 (millions $)
  • Agilent in Genomics
  • Cytogenetic Analysis
  • Sequencing
  • Flow Cytometry
  • Companion Diagnostics - Dako
  • COVID-19
  • Becton, Dickinson and Company (BD)
  • Recent Revenue History
    • Table 15-4: BD Diagnostic Revenues 2017-2021 (millions $)
  • Cytology
  • Molecular Microbiology
  • Traditional Microbiology - ID/AST
  • Blood Culture
  • Hospital Acquired Infections
  • Blood Collection
  • Mass Spectrometry
  • Flow Cytometry
  • COVID-19
  • bioMérieux Inc.
  • Recent Revenue History
    • Table 15-5: bioMérieux IVD Revenues 2017-2021 (millions $)
  • Traditional Microbiology
  • Blood Culture
  • Immunoassays
  • Mass Spectrometry
  • BioFire Diagnostics Business
  • COVID-19
  • Bio-Rad Laboratories, Inc.
  • Recent Revenue History
    • Table 15-6: Bio-Rad Diagnostics Revenues 2017-2021 (millions $)
  • Blood Bank
  • Immunoassays
  • Danaher Corporation
    • Table 15-7: Danaher Global IVD Diagnostic Sales, 2017-2021 ($million)
  • Dexcom
  • Recent Revenue History
    • Table 15-8: Dexcom IVD Diagnostic Sales, 2017-2021 ($million)
  • DiaSorin
  • Recent Revenue History
    • Table 15-9: DiaSorin Revenues 2017-2021 (millions $)
  • Immunoassays
  • Molecular
  • COVID-19
  • Exact Sciences
  • Recent Revenue History
    • Table 15-10: Exact Sciences Revenues 2017-2021 (millions $)
  • COVID-19
  • Hologic, Inc.
  • Recent Revenue History
    • Table 15-11: Hologic Revenues 2017-2021 (millions $)
  • PANTHER Molecular System
  • HIV Testing
  • Sexually Transmitted Infections
  • Infectious Diseases
  • Cytology
  • COVID-19
  • Illumina
  • Recent Revenue History
    • Table 15-12: Illumina Diagnostics Revenues 2017-2021 (millions $)
  • COVID-19
  • Ortho Clinical Diagnostics (Ortho)
  • Recent Revenue History
    • Table 15-13: Ortho Clinical Diagnostics Revenues 2017-2021 (millions $)
  • Blood Bank
  • Core Lab / Immunoassays
  • COVID-19
  • PerkinElmer, Inc
  • Recent Revenue History
    • Table 15-14: PerkinElmer IVD Revenues 2017-2021 (millions $)
  • Diagnostics
  • COVID-19
  • QIAGEN
  • Recent Revenue History
    • Table 15-15: QIAGEN IVD Revenues 2017-2021 (millions $)
  • Tuberculosis
  • Precision Medicine / Companion Diagnostics
  • Molecular Microbiology
  • Prenatal Testing
  • Next Generation Sequencing
  • Liquid Biopsy
  • COVID-19
  • Roche Diagnostics
  • Recent Revenue History
    • Table 15-16: Roche Diagnostics IVD Revenues 2017-2021 (millions $)
  • Hematology
  • Core Lab
  • Immunoassays
  • HIV
  • Core Molecular
  • Digital PCR
  • Diabetes Care
  • Coagulation
  • cobas Liat System - POC
  • HPV
  • Blood Bank
  • Transplant Medicine
  • Cancer Companion Testing
  • COVID-19
  • Siemens Healthineers (Siemens)
  • Recent Revenue History
    • Table 15-17: Siemens Healthineers IVD Revenues 2017-2021 (millions $)
  • Core Lab
  • Immunoassays
  • Hematology
  • Molecular
  • Acute Care - POC
  • COVID-19
  • Sysmex Corporation
  • Recent Revenue History
    • Table 15-18: Sysmex IVD Revenues 2017-20121(millions $)
  • Hematology
  • Coagulation
  • Urinalysis
  • Immunoassays
  • Flow Cytometry
  • Precision Medicine / Companion Test Diagnostics
  • Oncology
  • COVID-19
  • Thermo Fisher Scientific Inc.
  • Recent Revenue History
    • Table 15-19: Thermo Fischer IVD Revenues 2017-2021 (millions $)
  • Immunoassays
  • Microbiology
  • Next Generation Sequencing
  • qPCR
  • Mass Spectrometry
  • COVID-19
  • Werfen
  • Recent Revenue History
    • Table 15-20: Werfen IVD Revenues 2017-2021 (millions $)
  • Hematology
  • Advanced Cell Diagnostics (ACD)
  • Autoimmunity